Landos Biopharma, Inc.
Landos Biopharma, Inc. (LABP) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 52 transactions totaling $59.7M, demonstrating a bullish sentiment with $53.1M in net insider flow. The most recent transaction on Feb 28, 2023 involved a sale of 786,299 shares valued at $0.
LABP Insider Activity Summary
Who Is Buying LABP Stock?
No significant insider buying has been recorded for LABP in the recent period.
Who Is Selling LABP Stock?
No significant insider selling has been recorded for LABP in the recent period.
Is Landos Biopharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LABP is bullish with an Insider Alignment Score of 95/100 and a net flow of $53.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
LABP Frequently Asked Questions
Understanding LABP Insider Activity
Insider trading at Landos Biopharma, Inc. (LABP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading LABP stock, having executed 52 transactions in the past 90 days. The most active insider is Advisors Llc Perceptive (Executive), who has made 12 transactions totaling $23.2M.
Related Tools
Track Landos Biopharma, Inc. Insider Activity
Get notified when executives and directors at LABP file new Form 4 transactions